Hosted on MSN2mon
Island Pharma's anti-dengue drug trial set to hit Phase 2b in Jan 2025 with FDA happyIsland Pharma (ASX:ILA) has reported seeing a “reduction in ... the company stated on Wednesday – greenlighting the company’s path to test the Phase 2b cohort of the study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback